β-Myrcene alleviates atopic dermatitis-like inflammation and is associated with ECM-FAK/Src-YAP signaling during epidermal barrier repair.
BACKGROUND Atopic dermatitis (AD) is characterized by epidermal barrier impairment and immune-driven inflammation. Strategies that restore barrier architecture while constraining inflammation are of therapeutic interest. PURPOSE To evaluate the barrier-reparative and anti-inflammatory effects of β-myrcene (MYR) in ex...